Home

Andreas Krebs

CIK 1438946 · President, EMEA & Canada · last filed 2026-06-15

Andreas Krebs is a President, EMEA & Canada who has filed 9 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for DFTX, was dated Jun 15, 2026. Current disclosed insider exposure totals $877.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$877.7K

Companies

3

Total Filings

9

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DFTX Director 19,773 $44.39 $877.7K $0 1 2026-06-15
Definium Therapeutics, Inc. (MNMD) Delisted Director 15,107 $15.00 $226.6K $0 5 2025-06-16
WYETH (WYE) Delisted President, EMEA & Canada 15,807 — — $0 2 2009-04-29

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-15 DFTX Grant (A) +4,666 $0 EDGAR
2025-06-16 Definium Therapeutics, Inc. (MNMD) Delisted Grant (A) — $0 EDGAR
2024-06-12 Definium Therapeutics, Inc. (MNMD) Delisted Grant (A) — $0 EDGAR
2023-06-23 Definium Therapeutics, Inc. (MNMD) Delisted Grant (A) +13,671 $0 EDGAR
2022-06-06 Definium Therapeutics, Inc. (MNMD) Delisted Grant (A) +21,552 $0 EDGAR
2022-06-03 Definium Therapeutics, Inc. (MNMD) Delisted Grant (A) +21,552 $0 EDGAR
2009-10-19 — Disp (D) −15,882 -$200.3K
2009-04-29 WYETH (WYE) Delisted Tax (F) −921 -$38.8K EDGAR
2009-03-03 WYETH (WYE) Delisted Mixed +2,251 -$70.8K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.